2 ms·
Depends on your vaccine. NEJM had a RWE study on Pfizer from Israel's data [1] that showed the 2nd shot had 92% efficacy against asymptomatic infection. Symptom
by jghn 6y ago
Depends on your vaccine. NEJM had a RWE study on Pfizer from Israel's data [1] that showed the 2nd shot had 92% efficacy against asymptomatic infection. Symptomatic infection was 94%.
[1]: https://www.nejm.org/doi/full/10.1056/NEJMoa2101765 https://www.nejm.org/doi/full/10.1056/NEJMoa2101765
- barbazoo 6y agoThat's fantastic, thank you.